Neuro-Oncology Reviews
Volume
28 Number 10
10 April 2026
Home > Publications > Neuro-Oncology Reviews > Volume 28, Year 2026 > Number 10, 10 April
Legge DM, Kirsten S, Dhillon HM, Pike KE, Laidsaar-Powell R, Breen
LJ, Gan HK, Halkett GKB.
Communication
guidelines for healthcare professionals working with adults with
changed cognitive capacity and their carers: A scoping review with
implications for neuro-oncology.
Patient
Educ Couns. 2026 Apr 1;149:109611. doi:
10.1016/j.pec.2026.109611. PMID:
41966602. ˍ
Long Z, Liu K.
The 15-year
bibliometric landscape of glioblastoma vaccines: Emergence of
combinatorial immunotherapy.
Hum
Vaccin Immunother. 2026 Apr 1;22(1):2650847. doi:
10.1080/21645515.2026.2650847. PMID:
41919662. ˍ
Fontão P, Viana-Pereira M, Pinto-Ribeiro F, Junqueira T,
Reis RM.
Outcomes of immunotherapy
in medulloblastoma: a systematic review.
Oncologist.
2026 Apr 6;31(6):oyag109. doi:
10.1093/oncolo/oyag109. PMID:
41950392. ˍ
Li J, Wu D, Chen Z, Miao C, Wang J, Luo Q.
Knowledge
Mapping of Exosomes in Glioblastoma: A Bibliometric Analysis From
2006 to 2025.
J
Craniofac Surg. 2026 Apr 6. doi:
10.1097/SCS.0000000000012707. PMID:
41941145˰ ˍ
Caniceiro AB, Agostinho SP, Piochi LF, Rosário-Ferreira N,
Moreira IS.
The GPCR Connection:
Linking Alzheimer's Disease and Glioblastoma.
J
Cell Mol Med. 2026 Apr 9;30(7):e71131. doi:
10.1111/jcmm.71131. PMID:
41958080. ˍ
Perreault S, Doz F.
TRK inhibitors
in pediatric gliomas.
Neurooncol
Adv. 2025 Nov 12;8(Suppl 2):ii25-ii30. doi:
10.1093/noajnl/vdaf179. PMID:
42059003. ˍ
Alshammari AJM, Hargrave D, Das A.
RAS/MAPK
inhibition in pediatric gliomas.
Neurooncol
Adv. 2025 Dec 2;8(Suppl 2):ii3-ii13. doi:
10.1093/noajnl/vdaf007. PMID:
42058999. ˍ
Mullins A, Bennett J, Yeo KK, Lim-Fat MJ.
Targeted
therapies in adolescent and young adult patients with central
nervous system tumors.
Neurooncol
Adv. 2025 Dec 2;8(Suppl 2):ii59-ii70. doi:
10.1093/noajnl/vdaf043. PMID:
42059000. ˍ
Zhu J, Tsoli M, Bertoldo J, Mueller S, Ziegler DS.
A
new hope: Clinical advances in targeted therapies for pediatric
diffuse midline glioma.
Neurooncol
Adv. 2025 Dec 2;8(Suppl 2):ii41-ii58. doi:
10.1093/noajnl/vdaf008. PMID:
42059004. ˍ
Cassim S, Montemagno C.
Neural
Innervation of Tumors: Mechanisms, Hallmarks, and Therapeutic
Opportunities.
Cancers
(Basel). 2026 Mar 25;18(7):1063. doi:
10.3390/cancers18071063. PMID:
41976286. ˍ
Pernia Marin M, Almabrok H, Miller ML, Haggiagi A.
The
Elusive Origin of Glioblastoma: Where Do We Stand?
Cells.
2026 Mar 26;15(7):590. doi:
10.3390/cells15070590. PMID:
41972682. ˍ
Guo S, Zhao W, Liu J, Wang N, Ji P, Wang L, Wang Y.
Mapping
the global research landscape and innovations on elderly glioma: a
bibliometric analysis.
Front
Oncol. 2026 Mar 27;16:1769459. doi:
10.3389/fonc.2026.1769459. PMID:
41971454. ˍ
Moeini Y, Bakhshi A, Ghoflchi S, Taghavi A, Hosseini H, Jalili-Nik
M.
Curcumin Analogs in Glioblastoma
Therapy: A Narrative Review.
Curr
Med Chem. 2026 Mar 30. doi:
10.2174/0109298673428440260303054650. PMID:
41918192˰ ˍ